Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Hepatitis Health Center

Font Size

Response to Hep C Treatment Worse for Blacks

Only 19% of Black Patients Are Cured vs. 52% for Whites

Response Rate Lower Than in Whites, But Better Than the Past continued...

Muir tells WebMD that despite the difference in treatment outcomes, it would never be justifiable to withhold hepatitis C treatment on the basis of race alone. He points out that the 19% response rate to treatment seen among blacks is higher than that achieved in all patients treated with early hepatitis C drugs just over a decade ago.

"The decision to treat any hepatitis C patient is a complex one, and this is just one of the factors that needs to be weighed in discussions between physicians and African-American patients," he says.

Patients Still Benefit

Alexandria, Virginia physician Jonathan McCone, MD, who was a participating investigator in the Duke study, adds that many patients who do not achieve sustained responses to treatment still seem to benefit from it.

"I have seen this personally in my practice and studies have shown this," McCone tells WebMD. "Therapy actually reverses some of the liver damage and buys patients time by keeping them healthy so they don't degenerate to the point of needing a liver transplant or developing liver cancer."

McCone added that findings from this and other studies can be seen as encouraging because responses to early hepatitis C treatments among black patients was close to zero.

"Just a few years ago response to treatment was poor for everybody and absolutely horrible for African Americans," he says. "We now see sustained viral clearance in 20%-25% of a historically difficult to treat population. That is pretty significant."

SOURCES: Muir et al., The New England Journal of Medicine, May 27, 2004; Vol. 350: pp. 2265-2271. Andrew J. Muir, MD, assistant professor of medicine, division of gastrointerology, Duke University Medical Center, Durham, NC. Jonathan McCone, MD, director, Mount Vernon Endoscopy Center, Alexandria, VA. Bruce Bacon, MD, professor of internal medicine; division of gastrointerology and hepatology, St. Louis University School of Medicine.

1 | 2

Today on WebMD

Hepatitus C virus
Types, symptoms and treatments.
liver illustration
Myths and facts about this essential organ.
woman eating apple
What you need to know.
doctor and patient
What causes it?
Hepatitis C Treatment
Syringes and graph illustration
liver illustration
passport, pills and vaccine
Scientist looking in microscope
Fatty Liver Disease
Digestive Diseases Liver Transplantation
Picture Of The Liver
Image Collection